MeiraGTx Holdings Management
Management criteria checks 3/4
MeiraGTx Holdings' CEO is Alexandria Forbes, appointed in Mar 2015, has a tenure of 9.17 years. total yearly compensation is $6.34M, comprised of 10.2% salary and 89.8% bonuses, including company stock and options. directly owns 2.18% of the company’s shares, worth $7.01M. The average tenure of the management team and the board of directors is 5 years and 8.9 years respectively.
Key information
Alexandria Forbes
Chief executive officer
US$6.3m
Total compensation
| CEO salary percentage | 10.2% |
| CEO tenure | 9.2yrs |
| CEO ownership | 2.2% |
| Management average tenure | 5yrs |
| Board average tenure | 8.9yrs |
Recent management updates
Recent updates
MeiraGTx: Bota-Vec Program Advancing With Milestones Being Met
Feb 15Does MeiraGTx Holdings (NASDAQ:MGTX) Have A Healthy Balance Sheet?
Sep 08
Calculating The Intrinsic Value Of MeiraGTx Holdings plc (NASDAQ:MGTX)
Apr 11MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Reducing Their Forecasts For This Year
Mar 16MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are More Bearish Than They Used To Be
Nov 16MeiraGTx GAAP EPS of -$0.76, revenue of $10.76M
Aug 11MeiraGTx inks $100M debt agreement backed by manufacturing facilities
Aug 03MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans
Apr 29Analysts' Revenue Estimates For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher
Mar 15MeiraGTx: Perceptive's Large Stake Makes It Interesting
Jan 19MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans
Dec 28MeiraGTx: Novel Riboswitch Technology Could Add Value
Nov 01Shareholders Will Probably Hold Off On Increasing MeiraGTx Holdings plc's (NASDAQ:MGTX) CEO Compensation For The Time Being
Jun 05MeiraGTx Holdings'(NASDAQ:MGTX) Share Price Is Down 11% Over The Past Year.
Feb 22Is MeiraGTx Holdings plc (NASDAQ:MGTX) Popular Amongst Insiders?
Jan 18
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$6m | US$648k | -US$84m |
| Sep 30 2023 | n/a | n/a | -US$132m |
| Jun 30 2023 | n/a | n/a | -US$125m |
| Mar 31 2023 | n/a | n/a | -US$129m |
| Dec 31 2022 | US$8m | US$580k | -US$130m |
| Sep 30 2022 | n/a | n/a | -US$112m |
| Jun 30 2022 | n/a | n/a | -US$101m |
| Mar 31 2022 | n/a | n/a | -US$87m |
| Dec 31 2021 | US$6m | US$580k | -US$80m |
| Sep 30 2021 | n/a | n/a | -US$80m |
| Jun 30 2021 | n/a | n/a | -US$61m |
| Mar 31 2021 | n/a | n/a | -US$66m |
| Dec 31 2020 | US$8m | US$602k | -US$58m |
| Sep 30 2020 | n/a | n/a | -US$53m |
| Jun 30 2020 | n/a | n/a | -US$57m |
| Mar 31 2020 | n/a | n/a | -US$52m |
| Dec 31 2019 | US$8m | US$580k | -US$55m |
| Sep 30 2019 | n/a | n/a | -US$70m |
| Jun 30 2019 | n/a | n/a | -US$75m |
| Mar 31 2019 | n/a | n/a | -US$86m |
| Dec 31 2018 | US$23m | US$555k | -US$85m |
| Sep 30 2018 | n/a | n/a | -US$73m |
| Jun 30 2018 | n/a | n/a | -US$66m |
| Mar 31 2018 | n/a | n/a | -US$42m |
| Dec 31 2017 | US$1m | US$450k | -US$32m |
Compensation vs Market: Alexandria's total compensation ($USD6.34M) is above average for companies of similar size in the US market ($USD2.41M).
Compensation vs Earnings: Alexandria's compensation has been consistent with company performance over the past year.
CEO
Alexandria Forbes (58 yo)
9.2yrs
Tenure
US$6,336,832
Compensation
Dr. Alexandria Forbes, Ph.D. serves as the Chief Executive Officer, Director and President at MeiraGTx Holdings plc (formerly known as MeiraGTx Limited) since March 2015. Prior to joining MeiraGTx, Dr. For...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 9.2yrs | US$6.34m | 2.18% $ 7.0m | |
| COO & CFO | 9.2yrs | US$4.98m | 1.45% $ 4.7m | |
| Chief Development Officer | 9.1yrs | US$2.50m | 0.88% $ 2.8m | |
| General Counsel & Secretary | 4.8yrs | no data | 0.024% $ 75.7k | |
| Head of Clinical Ophthalmology | 3.3yrs | no data | no data | |
| Senior Vice President of Global Integration | no data | no data | no data | |
| Senior Vice President of Risk & Internal Controls | 5.1yrs | no data | no data | |
| Senior Vice President of Manufacturing & Supply Chain | 4.8yrs | no data | no data | |
| Chief Medical Officer | 3.8yrs | US$4.05m | 0.14% $ 448.6k |
5.0yrs
Average Tenure
56.5yo
Average Age
Experienced Management: MGTX's management team is considered experienced (5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 9.2yrs | US$6.34m | 2.18% $ 7.0m | |
| Member of Scientific Advisory Board | no data | US$149.82k | 0% $ 0 | |
| Independent Director & Member of Scientific Advisory Board | 8.9yrs | US$347.73k | 0% $ 0 | |
| Independent Chairman of the Board | 8.9yrs | US$538.84k | 0.031% $ 100.0k | |
| Independent Director | 5yrs | US$395.76k | 0.0078% $ 25.0k | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 8.9yrs | US$352.73k | 0.020% $ 64.4k | |
| Director | 6.6yrs | US$264.23k | 0% $ 0 | |
| Independent Director | 5.3yrs | US$340.23k | 0.023% $ 75.0k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
8.9yrs
Average Tenure
68.5yo
Average Age
Experienced Board: MGTX's board of directors are considered experienced (8.9 years average tenure).